Inspection has become a standard assessment of any manufacturing system. It is the means of rejecting nonconformities and assuring good quality products. The advent of technologically updated inspection equipment helped to overcome the problems associated with traditional approaches. Traditional approach used labour-intensive methods that resulted in the increase of manufacturing lead time and production cost. Moreover, there is a significant delay in detecting an out of control limit. Thus, the products that are not conforming to the specified standards accrue to the additional cost of scrap and rework. “Meticulous Research” in its latest publication states that, the “global market for inspection machines is expected to grow at a CAGR of 5.7% from 2017 to 2022 to reach $846.4 million by 2022.”
This growth is primarily driven by the growing aging population, rapid growth of pharmaceutical market, increasing chronic and infectious disease cases, growing need of GMP compliance, and technological advancements across the globe.
According to WHO, the objective of inspecting pharmaceuticals is to enforce the GMP (Good Manufacturing Practices), a system for ensuring the standards of quality products to eliminate the hazard posed by the infiltration of counterfeit drugs. It is necessary to determine whether all establishments participating in the manufacture of the finished dosage form are in compliance with GMP, before any application is approved. However, the guidelines of pre-approval inspection unveil that the inspection is not normally carried out routinely.
The inspection is performed only in specific cases where non-compliance is possible and thus, the need of inspection may be required for: new chemical entities, product which are previously associated with serious adverse effects, complaints, and recalls; products that are difficult to manufacture or test or of doubtful stability; new applicant or manufactures and applications from manufactures who have previously failed to comply with GMP.
Another reason accounted for raising need of inspection in pharmaceutical industry includes the regulatory follow up by inspectorate (inspection group of the Drug Regulatory Authority) which recommends withholding approval when deviated from GMP requirements. Thus, the growing need to comply with GMP guidelines drives the adoption of inspection machines across the globe.
The report provides meticulous analysis of inspection machines market on the basis of technology (automatic and semi-automatic), component (pharma/biopharma products, packaging, and medical devices), and geography.
The key players analyzed in the inspection machines market are ACG Worldwide, Brevetti C.E.A. Spa, NKP Pharma, Antares Vision S.r.l., Stevanato Group, Bausch + Ströbel, Robert Bosch GmbH, Jeckson Vision, Körber AG (Seidenader Maschinenbau GmbH, Medipak Systems), Optel Group, Sainty International Group, and Daiichi Jitsugyo Viswill Co., Ltd.
For detailed Table of Content; Download free sample report here